Dataset opportunity
Shipmercury — Regulatory Records Dataset Opportunity
Moderate regulatory records dataset held by Shipmercury, usable for Regulatory RAG and Compliance Copilots.
Score
69.1
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
58%
Action
Acquire
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global Pharmaceutical Logistics Market to reach $119.56 billion in 2026, growing at a CAGR of 8.8% (2026-2034).
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- 📝Published article
AI and Real-Time Monitoring in Cold Chain Logistics
source ↗
Profile
Dataset profile
Type
Regulatory Records Dataset
Modality
Text
Sector
mobility
Volume
Moderate
Freshness
Real-time
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Mixed ownership — licensing rights to clarify
Buyer persona
RegTech & compliance-AI vendors
Shipmercury provides a Regulatory Records Dataset in Text modality, compiled from its specialized biopharma logistics operations. The data includes business records, IoT telemetry, and a knowledge base of regulatory protocols, making it exceptionally well-suited for developing a Regulatory RAG system to navigate complex compliance and supply chain queries.
This data operates within the global pharmaceutical logistics market, which is projected to be worth $119.56 billion in 2026 and expand at a CAGR of 8.8%. [1] While access to this valuable dataset is subject to healthcare regulations like GDP compliance and requires client anonymization, its rarity and direct application for AI in a high-growth, regulated sector present a significant opportunity for buyers. ⚠ Diligence (valuable data, access to negotiate): Logistics telemetry (GPS/Temp) is proprietary but shipment contents belong to clients.; Subject to healthcare logistics regulations (GDP compliance).; Data access likely requires anonymization of specific biopharma client identities. · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Shipmercury owns a proprietary dataset detailing the complex regulatory and logistical realities of pharmaceutical shipping. This data documents real-world practices in a global pharmaceutical logistics market projected to exceed $119 billion, making it a high-value asset for RegTech and compliance-AI vendors. It provides the authentic ground-truth needed to power a sophisticated Regulatory RAG model with examples of customs documentation, cold chain handling, and chain-of-custody protocols, offering a distinct competitive advantage.
See dimension details ↓- ICP Audit92
✓ good target — Shipmercury is a specialized logistics company for the life sciences sector, not a data seller; its operational shipping and regulatory compliance data is a valuable, dormant by-product, making it an ideal target. Issues: The initial description 'Regulatory Records Dataset Opportunity' was misleading; the company's core business is clearly logistics, not selling this data.; Company size estimates vary across sources, ranging from 71 to 126 employees, but all fall within a reasonable SME definition. [13, 12]
- Deep Qualification80
⚠ needs review — Shipmercury is a specialized logistics provider for the life sciences sector, generating valuable regulatory and telemetry data as a by-product. While data ownership is mixed and their privacy policy explicitly restricts selling customer lists, the recent acquisition of King Courier indicates strategic growth, making the aggregated, anonymized portion of their data a viable, though complex, opportunity. [licensing restricted]
- Dataset Specificity78
dominant 'regulatory', sector mobility, 2 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume64
5 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Regulatory RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand90
AI buyer demand is high, driven by the critical need to automate compliance and enhance efficiency in the large pharmaceutical logistics market, which is expanding at a strong 8.8% CAGR. [1]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility28
restricted/unknown
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility30
medium difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength77
4 evidence types, 5 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License36
ownership=mixed, licensing=rights_unclear
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation39
1 data-appetite signals (1 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Knowledge base / docs
This evidence confirms the existence of text records detailing international shipping for life sciences clients, including processes for customs documentation and the handling of commercial drugs.
IoT / sensor data
This sample proves the operational context behind the text records, showing that Shipmercury actively monitors temperature control for shipments, a critical component of cold chain compliance.
business_records
These records demonstrate a history of managing life sciences logistics, providing further evidence of sustained operations and proactive tracking across domestic and international service lanes.
Regulatory records
This text explicitly confirms the dataset contains information on managing biopharmaceutical supply chains, with a focus on regulatory compliance and chain-of-custody visibility.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Shipmercury Regulatory Records — a Moderate regulatory records dataset (Text modality) in the mobility domain. Primary AI use-case: Regulatory RAG. Market signal: Global Pharmaceutical Logistics Market to reach $119.56 billion in 2026, growing at a CAGR of 8.8% (2026-2034). [1]. Investment score 69.1/100 (confidence 0.58). Recommended action: Acquire.
From the marketplace
Explore live data opportunities
Rigitrac — Maintenance Logs Dataset Opportunity
View opportunity →mobilityNussbaum — Maintenance Logs Dataset Opportunity
View opportunity →mobilityZeebafleet — Maintenance Logs Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- What you are entitled to sell3 min read
- 5 Mistakes That Drive Buyers Away3 min read
- Why Buy External Data?3 min read